期刊文献+

食管癌预后相关免疫因素研究进展 被引量:2

Progress of prognosis-related immune factors in esophageal neoplasms
原文传递
导出
摘要 近年来,免疫治疗成为一种新的治疗手段。介导肿瘤免疫的相关细胞及细胞因子在肿瘤免疫过程中呈现出不同作用,且与肿瘤预后呈相关性,对肿瘤预后的评估具有一定参考意义。食管癌是我国消化系统的常见肿瘤之一,5年总生存率低,随着免疫治疗的广泛应用及精准医疗的问世,探讨肿瘤免疫相关细胞、细胞因子及食管癌预后的关系,可对食管癌的诊治提供指导。 Immunotherapy has recently become a new therapeutic method.Related cells and cytokines mediating tumor immunity play different roles in the process of tumor immunity,and they are correlated with tumor prognosis,which has a reference significance in the evaluation of tumor prognosis.In China,esophageal carcinoma is one of the common tumors of digestive system,and its 5-year overall survival rate is low.With the wide use of immunotherapy and introduction of precision medicine,the study on the relationship between tumor immune-related cells,cytokines and the prognosis of esophageal carcinoma can provide the guidance for the diagnosis and treatment of esophageal carcinoma.
作者 鄢敏 唐丽娜 邓世山 李德智 Yan Min;Tang Lina;Deng Shishan;Li Dezhi(Department of Oncology,Nanchong City Central Hospital Affiliated to North Sichuan Medical College,Nanchong 637000,China;Basic Medical School,North Sichuan Medical College,Nanchong 637000,China)
出处 《肿瘤研究与临床》 CAS 2020年第8期590-592,共3页 Cancer Research and Clinic
基金 四川省教育厅创新团队项目(17TD0016) 四川省南充市科技与知识产权局创新驱动发展专项(16CXQD0042)。
关键词 食管肿瘤 预后 免疫系统 细胞因子类 Esophageal neoplasms Prognosis Immune system Cytokines
  • 相关文献

参考文献3

二级参考文献27

  • 1张治,张伟,许林,张勤,俞明锋,刘建良,袁方良,孙来荣.食管癌、贲门癌患者T细胞亚群水平及临床意义[J].江苏医药,2007,33(3):231-232. 被引量:14
  • 2宁军,龚浩.中晚期肿瘤患者T淋巴细胞和NK细胞检测的临床意义[J].实用全科医学,2007,5(7):587-588. 被引量:12
  • 3Terabe M,Berzofsky JA.The role of NKT cells in tumor immunity.Adv Cancer Res,2008,101:277-348.
  • 4Baev DV,Peng XH,Song L,et al.Distinct homeostatic requirements of CD+4 and CD-4 subsets of Valpha 24-invariant natural killer T cells in humans.Blood,2004.104:4150-4156.
  • 5Kawano T,Cui J,Koezuka Y,et al.CD1d-restricted and TCR-mediated activation of alpha 14 NKT cells by glycosylceramides.Science,1997,278:1626-1629.
  • 6Kitamura H.The natural killer T (NKT) cell ligand alpha-galactosyl ceramide demonstrates its immunopotentiating effect by inducing inter leukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.J Exp Med,1999,189:1121-1128.
  • 7Ishikawa A,Motohashi S,Ishikawa E.A phase Ⅰ study of alphagalactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.Clin Cancer Res,2005,11:1910-1917.
  • 8Chang DH,Osman K,Connolly J,et al.Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosylceramide loaded mature dendritic cells in cancer patients.J Expe Med,2005,201:1503-1517.
  • 9Moodycliffe AM,Nghiem D,Clydesdale G,et al.Immunosuppression and skin cancer development:regulation by NKT cells.Nat Immunol,2000,1:521-525.
  • 10Iizuka A,Ikarashi Y,Yoshida M,et al.Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion,which is regulated by NKT cell-derived interferon-gamma and IL-4.Immunology,2008,123:100-107.

共引文献12

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部